Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
J Biomol Struct Dyn
; 36(15): 3938-3957, 2018 Nov.
Article
em En
| MEDLINE
| ID: mdl-29281938
Palavras-chave
AD; Alzheimer's disease; ADMET; ADMET; Absorption, Distribution, Metabolism, Excretion, and Toxicity; AR; Aromatic Ring; Alzheimer's disease (AD); COMT; Catechol-O-Methyltransferase; DNC; 3, 5-dinitrocatechol; DUDE; A Database of Useful (Docking) Decoys-Enhanced; FAF; Drug3-Free ADME-Tox Filtering Tool; GH; Güner-Henry; HBA; Hydrogen Bond Acceptor; HBD; Hydrogen Bond Donor; HYP; Hydrophobic; MD; Molecular Dynamics; MMFF94; Merck Molecular Force Field94; Mg+2; Magnesium ion; PD; Parkinson's disease; PDB; Protein Data Bank; RDF; Radial Distribution Function; RMSD; Root-mean-square-deviation; RMSF; Root-mean-square Fluctuations; SAM; S-Adenosyl L- Methionine; YASARA; Yet Another Scientific Artificial Reality Application; ZINC pharmer; ZINC39411941_412; (N-[3-[(2R)-5-benzoyl-2H-benzimidazol-2-yl]phenyl]cyclopropanecarboxamide); ZINC63234426_254; ((4S)-4-(2H-benzimidazol-2-yl)-1-(1-naphthyl) pyrrolidin-2-one); ZINC63625100_413; ((2R)-N-[3-[2-(2H-benzimidazol-2-yl)ethyl]phenyl]-2H-indole-2-carboxamide); ZINC63637968_451; (N-[2-(2H-benzimidazol-2-yl)phenyl]-4-benzylbenzamide); ZINC64019452_303; (2-(2H-benzimidazol-2-yl)-N-phenethyl-benzamide); catechol-o-methyltransferase (COMT); molecular dynamics; pharmacophore
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Catecol O-Metiltransferase
/
Nootrópicos
/
Ensaios de Triagem em Larga Escala
/
Inibidores de Catecol O-Metiltransferase
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article